13010 related articles for article (PubMed ID: 10026924)
1. Application of gene transfer in cancer immunotherapy. From experimental data to clinical protocols.
Favrot MC; Puisieux I
Adv Exp Med Biol; 1998; 451():539-41. PubMed ID: 10026924
[No Abstract] [Full Text] [Related]
2. Improving the retroviral vector (RV) systems for immunotherapy of cancer.
Grabarczyk P; Gryska K; Wysocki PJ; Izycki D; Mackiewicz A
Adv Exp Med Biol; 2001; 495():389-92. PubMed ID: 11774599
[No Abstract] [Full Text] [Related]
3. Immunologic approaches to the treatment of cancer.
Figlin RA; Gitlitz BJ; Belldegrun A
Cancer Invest; 1995; 13(3):339-40. PubMed ID: 7743386
[No Abstract] [Full Text] [Related]
4. Interleukin-7 gene transfer in patients with metastatic colon carcinoma, renal cell carcinoma, melanoma, or with lymphoma.
Schmidt-Wolf IG; Huhn D; Neubauer A; Wittig B
Hum Gene Ther; 1994 Sep; 5(9):1161-8. PubMed ID: 7530496
[No Abstract] [Full Text] [Related]
5. The emergence of modern cancer immunotherapy.
Rosenberg SA
Ann Surg Oncol; 2005 May; 12(5):344-6. PubMed ID: 15843873
[No Abstract] [Full Text] [Related]
6. Cellular vaccine therapies for cancer.
Mastrangelo MJ; Sato T; Lattime EC; Maguire HC; Berd D
Cancer Treat Res; 1998; 94():35-50. PubMed ID: 9587681
[No Abstract] [Full Text] [Related]
7. Cancer immunotherapy comes of age.
Rosenberg SA
Nat Clin Pract Oncol; 2005 Mar; 2(3):115. PubMed ID: 16264884
[No Abstract] [Full Text] [Related]
8. Gene-modified immunotherapy for renal cell carcinoma.
Kawai K; Tani K; Asano S; Akaza H
Contrib Nephrol; 1999; 128():75-81. PubMed ID: 10597379
[No Abstract] [Full Text] [Related]
9. Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: phase I/II experience.
Galanis E; Hersh EM; Stopeck AT; Gonzalez R; Burch P; Spier C; Akporiaye ET; Rinehart JJ; Edmonson J; Sobol RE; Forscher C; Sondak VK; Lewis BD; Unger EC; O'Driscoll M; Selk L; Rubin J
J Clin Oncol; 1999 Oct; 17(10):3313-23. PubMed ID: 10506635
[TBL] [Abstract][Full Text] [Related]
10. Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene.
Stingl G; Brŏcker EB; Mertelsmann R; Wolff K; Schreiber S; Kămpgen E; Schneeberger A; Dummer W; Brennscheid U; Veelken H; Birnstiel ML; Zatloukal K; Schmidt W; Maass G; Wagner E; Baschle M; Giese M; Kempe ER; Weber HA; Voigt T
Hum Gene Ther; 1996 Mar; 7(4):551-63. PubMed ID: 8800750
[No Abstract] [Full Text] [Related]
11. A phase I study of adenovirus mediated gene transfer of interleukin 2 cDNA into metastatic breast cancer or melanoma.
Stewart AK; Lassam NJ; Graham FL; Gauldie J; Addison CL; Bailey DJ; Dessureault S; Dubé ID; Gallenger S; Krajden M; Rotstein LE; Quirt IC; Moen R
Hum Gene Ther; 1997 Jul; 8(11):1403-14. PubMed ID: 9295135
[No Abstract] [Full Text] [Related]
12. Fighting cancer with designer cells.
Culliton BJ
Science; 1989 Jun; 244(4911):1430-3. PubMed ID: 2660264
[No Abstract] [Full Text] [Related]
13. Immunotherapy for metastatic cancer. Establishing a 'proof of principle'.
Hellman S
JAMA; 1994 Mar 23-30; 271(12):945-6. PubMed ID: 8120965
[No Abstract] [Full Text] [Related]
14. Combined shock-wave and immunogene therapy of mouse melanoma and renal carcinoma tumors.
Song J; Tata D; Li L; Taylor J; Bao S; Miller DL
Ultrasound Med Biol; 2002 Jul; 28(7):957-64. PubMed ID: 12208340
[TBL] [Abstract][Full Text] [Related]
15. [Carcinogenesis and immunobiology of tumors. Scientific and clinical aspects].
Granov AM; Molchanov OE
Vopr Onkol; 2008; 54(4):401-9. PubMed ID: 18942393
[No Abstract] [Full Text] [Related]
16. Immune gene therapy for kidney cancer: the search for a magic trigger.
Kim HL; Belldegrun AS; Figlin RA
Mol Ther; 2003 Feb; 7(2):153-4. PubMed ID: 12597902
[No Abstract] [Full Text] [Related]
17. Treatment of metastatic melanoma and renal cell carcinoma with interleukin-2.
Manson LA
JAMA; 1994 Nov; 272(17):1327. PubMed ID: 7933390
[No Abstract] [Full Text] [Related]
18. [Not Available].
Rupp NJ; Mischo A; Moch H
Ther Umsch; 2017 Sep; 74(4):171-179. PubMed ID: 28950771
[No Abstract] [Full Text] [Related]
19. Adoptive immunotherapy using lymphokine-activated killer cells.
Fowler JE
J Urol; 1988 Jan; 139(1):148-9. PubMed ID: 3257273
[No Abstract] [Full Text] [Related]
20. Immunotherapy of renal cell carcinoma by intratumoral administration of an IL-2 cDNA/DMRIE/DOPE lipid complex.
Daniels GA; Galanis E
Curr Opin Mol Ther; 2001 Feb; 3(1):70-6. PubMed ID: 11249734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
